INTEG B — Integrum AB Share Price
Last trade - 00:00- SEK247.97m
- SEK238.56m
- SEK104.12m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.53 | ||
| Price to Tang. Book | 2.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 2.75 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -16.86% | ||
| Return on Equity | -13% | ||
| Operating Margin | -31.14% | ||
Financial Summary
| Year End 30th Apr | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 26.75 | 43.09 | 55.72 | 74.27 | 104.12 | 92 | 136 | 35.91% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Integrum AB is a Sweden-based company within healthcare sector. It provides systems for bone-anchored prostheses for individuals with amputations. The Company’s solutions comprise OPRA Implant System, neural prosthetics, phantom limb pain treatment and prosthetic components. The OPRA implant system is based on osseointegration, enabling the direct connection of an artificial limb to the skeleton. The neural prosthetics technology implies ability to directly connect bionic prostheses to the patient’s bone, nerves, and muscles. A method for limb pain treatment implies motor execution of the phantom limb as a treatment, which is aided by machine learning, augmented and virtual reality. The Company provides a variety of prosthetic components required to connect the OPRA Implant System to external prostheses.
Directors
- Rickard Branemark CHM (58)
- Maria Lopez CEO (37)
- Dennis Baecklund CFO
- Anna-Tove Branemark CEX (50)
- Thomas Dugan CEX
- Niklas Hofverberg OTH (45)
- Max Ortiz Catalan OTH (35)
- Artur Aira DRC
- Andrew Christensen DRC (43)
- Lennart Ramberg DRC (57)
- Magnus Rene DRC (59)
- Last Annual
- April 30th, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- October 2nd, 1990
- Public Since
- May 15th, 2017
- No. of Shareholders
- 3,901
- No. of Employees
- 36
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 18,756,828
- Address
- Gemenskapens gata 9, MOELNDAL, 431 53
- Web
- https://integrum.se/
- Phone
- +46 317601060
- Auditors
- PricewaterhouseCoopers AB
Upcoming Events for INTEG B
Similar to INTEG B
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
As of Today at 21:19 UTC, shares in Integrum AB are trading at SEK13.22. This share price information is delayed by 15 minutes.
Shares in Integrum AB last closed at SEK13.22 and the price had moved by -74.28% over the past 365 days. In terms of relative price strength the Integrum AB share price has underperformed the FTSE Global All Cap Index by -74.92% over the past year.
There is no consensus recommendation for this security.
Find out moreIntegrum AB does not currently pay a dividend.
Integrum AB does not currently pay a dividend.
Integrum AB does not currently pay a dividend.
To buy shares in Integrum AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of SEK13.22, shares in Integrum AB had a market capitalisation of SEK247.97m.
Here are the trading details for Integrum AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: INTEG B
Based on an overall assessment of its quality, value and momentum Integrum AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Integrum AB is SEK36.00. That is 172.31% above the last closing price of SEK13.22.
Analysts covering Integrum AB currently have a consensus Earnings Per Share (EPS) forecast of -SEK2.00 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Integrum AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -48.63%.
As of the last closing price of SEK13.22, shares in Integrum AB were trading -49.69% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Integrum AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK13.22.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Integrum AB's management team is headed by:
- Rickard Branemark - CHM
- Maria Lopez - CEO
- Dennis Baecklund - CFO
- Anna-Tove Branemark - CEX
- Thomas Dugan - CEX
- Niklas Hofverberg - OTH
- Max Ortiz Catalan - OTH
- Artur Aira - DRC
- Andrew Christensen - DRC
- Lennart Ramberg - DRC
- Magnus Rene - DRC